Refractory neurosarcoidosis responding to infliximab.
Morcos
Zeyad
Z
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001323:Autoantibodies; D006801:Humans; D000069285:Infliximab; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000209:etiology; D012507:Sarcoidosis / Q000150:complications* / Q000188:drug therapy*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000139:chemically induced
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D001323:Autoantibodies; D000069285:Infliximab